GB8703749D0 - Piperazinecarboxylic acid - Google Patents

Piperazinecarboxylic acid

Info

Publication number
GB8703749D0
GB8703749D0 GB878703749A GB8703749A GB8703749D0 GB 8703749 D0 GB8703749 D0 GB 8703749D0 GB 878703749 A GB878703749 A GB 878703749A GB 8703749 A GB8703749 A GB 8703749A GB 8703749 D0 GB8703749 D0 GB 8703749D0
Authority
GB
United Kingdom
Prior art keywords
piperazinecarboxylic acid
piperazinecarboxylic
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB878703749A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GB878703749A priority Critical patent/GB8703749D0/en
Publication of GB8703749D0 publication Critical patent/GB8703749D0/en
Priority to LU87129A priority patent/LU87129A1/fr
Priority to IT47631/88A priority patent/IT1219447B/it
Priority to BE8800177A priority patent/BE1002427A3/fr
Priority to FR888801782A priority patent/FR2610932B1/fr
Priority to MYPI88000155A priority patent/MY103206A/en
Priority to GB8803438A priority patent/GB2201676B/en
Priority to DK079688A priority patent/DK168441B1/da
Priority to CH549/88A priority patent/CH675125A5/de
Priority to HU88746A priority patent/HU199858B/hu
Priority to GR880100084A priority patent/GR1002471B/el
Priority to AU11758/88A priority patent/AU613009B2/en
Priority to IE41388A priority patent/IE59098B1/en
Priority to NZ223529A priority patent/NZ223529A/xx
Priority to IL85436A priority patent/IL85436A0/xx
Priority to PH36514A priority patent/PH25512A/en
Priority to CA000559170A priority patent/CA1327799C/fr
Priority to FI880744A priority patent/FI86733C/fi
Priority to PT86776A priority patent/PT86776B/pt
Priority to AT0036788A priority patent/AT391320B/de
Priority to SE8800541A priority patent/SE467256B/sv
Priority to JP63036458A priority patent/JPH0723387B2/ja
Priority to DE3804936A priority patent/DE3804936C2/de
Priority to KR1019880001680A priority patent/KR960015190B1/ko
Priority to NL8800412A priority patent/NL8800412A/nl
Priority to ZA881146A priority patent/ZA881146B/xx
Priority to ES888800466A priority patent/ES2011319A6/es
Priority to ES8903482A priority patent/ES2021904A6/es
Priority to HK1420/93A priority patent/HK142093A/xx
Priority to HU95P/P00176P priority patent/HU211269A9/hu
Priority to CY173995A priority patent/CY1739A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB878703749A 1987-02-18 1987-02-18 Piperazinecarboxylic acid Pending GB8703749D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GB878703749A GB8703749D0 (en) 1987-02-18 1987-02-18 Piperazinecarboxylic acid
LU87129A LU87129A1 (fr) 1987-02-18 1988-02-11 Nouvel acide piperazinecarboxylique,sa preparation et son utilisation comme medicament
IT47631/88A IT1219447B (it) 1987-02-18 1988-02-12 Acido piperrazincarbossilico, la sua preparazione e il suo impiego come medicamento
BE8800177A BE1002427A3 (fr) 1987-02-18 1988-02-12 Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament.
FR888801782A FR2610932B1 (fr) 1987-02-18 1988-02-12 Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament
MYPI88000155A MY103206A (en) 1987-02-18 1988-02-15 Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it
GB8803438A GB2201676B (en) 1987-02-18 1988-02-15 Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it
CA000559170A CA1327799C (fr) 1987-02-18 1988-02-16 Acide piperazinecarboxylique; methode de preparation; compositions pharmaceutiques a base de cet acide
IL85436A IL85436A0 (en) 1987-02-18 1988-02-16 Piperazinecarboxylic acid,its preparation and pharmaceutical compositions containing it
CH549/88A CH675125A5 (fr) 1987-02-18 1988-02-16
HU88746A HU199858B (en) 1987-02-18 1988-02-16 Process for producing piperazinecarboxylic acid derivatives and pharmaceutical compositions comprising such compound
GR880100084A GR1002471B (el) 1987-02-18 1988-02-16 Πιπεραζινκαρβοξυλικο οξυ,η παρασκευη του και φαρμακευτικες συνθεσεις που το περιεχουν.
AU11758/88A AU613009B2 (en) 1987-02-18 1988-02-16 4-(3-phosphono-2-propenyl)-2- piperazinecarboxylic acid
IE41388A IE59098B1 (en) 1987-02-18 1988-02-16 Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it
NZ223529A NZ223529A (en) 1987-02-18 1988-02-16 (r-(e))-4-(3-phosphono-2-propenyl)-2-piperazinecarboxylic acid and salts and pharmaceutical compositions
DK079688A DK168441B1 (da) 1987-02-18 1988-02-16 [R-(E)]-4-(3-phosphono-2-propenyl)-2-piperazincarboxylsyre, fremgangsmåde til fremstilling deraf, farmaceutisk præparat indeholdende forbindelsen samt anvendelse heraf
PH36514A PH25512A (en) 1987-02-18 1988-02-16 Piperazinecarboxylic acid, pharmaceutical compositions containing it
KR1019880001680A KR960015190B1 (ko) 1987-02-18 1988-02-17 피페라진카르복실산, 그의 염, 그들의 제조방법 및 그들을 함유하는 약학적 조성물
SE8800541A SE467256B (sv) 1987-02-18 1988-02-17 /r-(e)/-4-(3-fosfono-2-propenyl)-2-piperazinkarboxylsyra, foerfarande foer framstaellning av denna och en farmaceutisk komposition innehaallande foereningen
PT86776A PT86776B (pt) 1987-02-18 1988-02-17 Processo para a preparacao de acido piperazinocarboxilico e de composicoes farmaceuticas que o contem
AT0036788A AT391320B (de) 1987-02-18 1988-02-17 Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel
FI880744A FI86733C (fi) 1987-02-18 1988-02-17 Analogifoerfarande foer framstaellning av terapeutiskt anvaendbar piperazinkarboxylsyra
JP63036458A JPH0723387B2 (ja) 1987-02-18 1988-02-17 ピペラジンカルボン酸、その製造方法およびそれを含有する医薬組成物
DE3804936A DE3804936C2 (de) 1987-02-18 1988-02-17 Piperazincarbonsäure, ihre Herstellung und diese enthaltende Arzneimittel
ES888800466A ES2011319A6 (es) 1987-02-18 1988-02-18 Procedimiento para preparar acidos piperacinacarboxilicos.
NL8800412A NL8800412A (nl) 1987-02-18 1988-02-18 Piperazinecarbonzuurderivaat, bereiding ervan en farmaceutische preparaten die het bevatten.
ZA881146A ZA881146B (en) 1987-02-18 1988-02-18 Piperazinecarboxylic acid,its preparation and pharmaceutical compositions containing it
ES8903482A ES2021904A6 (es) 1987-02-18 1989-10-16 Procedimiento para preparar una composicion farmaceutica a base de un acido piperacinacarboxilico.
HK1420/93A HK142093A (en) 1987-02-18 1993-12-30 Piperazine-carboxylic acid,its preparation and pharmaceutical compositions containing it
HU95P/P00176P HU211269A9 (en) 1987-02-18 1995-06-09 Piperazinecarboxylic acid its preparation and pharmaceutical compositions containing it
CY173995A CY1739A (en) 1987-02-18 1995-10-20 Piperazinecarboxylic acid its preparation and pharmaceutical compositions containing it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878703749A GB8703749D0 (en) 1987-02-18 1987-02-18 Piperazinecarboxylic acid

Publications (1)

Publication Number Publication Date
GB8703749D0 true GB8703749D0 (en) 1987-03-25

Family

ID=10612501

Family Applications (2)

Application Number Title Priority Date Filing Date
GB878703749A Pending GB8703749D0 (en) 1987-02-18 1987-02-18 Piperazinecarboxylic acid
GB8803438A Expired - Lifetime GB2201676B (en) 1987-02-18 1988-02-15 Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB8803438A Expired - Lifetime GB2201676B (en) 1987-02-18 1988-02-15 Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it

Country Status (28)

Country Link
JP (1) JPH0723387B2 (fr)
KR (1) KR960015190B1 (fr)
AT (1) AT391320B (fr)
AU (1) AU613009B2 (fr)
BE (1) BE1002427A3 (fr)
CA (1) CA1327799C (fr)
CH (1) CH675125A5 (fr)
CY (1) CY1739A (fr)
DE (1) DE3804936C2 (fr)
DK (1) DK168441B1 (fr)
ES (2) ES2011319A6 (fr)
FI (1) FI86733C (fr)
FR (1) FR2610932B1 (fr)
GB (2) GB8703749D0 (fr)
GR (1) GR1002471B (fr)
HK (1) HK142093A (fr)
HU (2) HU199858B (fr)
IE (1) IE59098B1 (fr)
IL (1) IL85436A0 (fr)
IT (1) IT1219447B (fr)
LU (1) LU87129A1 (fr)
MY (1) MY103206A (fr)
NL (1) NL8800412A (fr)
NZ (1) NZ223529A (fr)
PH (1) PH25512A (fr)
PT (1) PT86776B (fr)
SE (1) SE467256B (fr)
ZA (1) ZA881146B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202111B (en) * 1988-03-11 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
EP0488959A3 (en) * 1990-11-28 1992-08-05 Sandoz Ltd. New uses of competitive nmda receptor antagonists
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
JPH11508761A (ja) * 1995-05-08 1999-08-03 ロンザ アーゲー Ｒ−α−ピペラジンカルボン酸およびＳ−α−ピペラジンカルボキサミドを製造する生物工学的方法
US6071915A (en) 1997-05-12 2000-06-06 Ortho-Mcneil Pharmaceutical, Inc. Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
GB9821179D0 (en) * 1998-09-30 1998-11-25 Merck Sharp & Dohme Therapeutic use
JP2008124531A (ja) 2006-11-08 2008-05-29 Nec Electronics Corp 半導体装置およびオーディオプロセッサチップ
EP3427729A1 (fr) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probénécide destiné à être utilisé dans le traitement de maladies, troubles ou états épileptiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248531A (fr) * 1984-04-17 1989-01-10 Jeffrey C. Watkins Derives de substitution en 4 d'acides piperazine-2- carboxyliques

Also Published As

Publication number Publication date
IE59098B1 (en) 1994-01-12
SE8800541D0 (sv) 1988-02-17
FI86733B (fi) 1992-06-30
CH675125A5 (fr) 1990-08-31
CA1327799C (fr) 1994-03-15
PT86776B (pt) 1992-05-29
KR880009944A (ko) 1988-10-06
GB8803438D0 (en) 1988-03-16
NZ223529A (en) 1991-02-26
AU613009B2 (en) 1991-07-25
DE3804936C2 (de) 1997-02-13
IL85436A0 (en) 1988-07-31
MY103206A (en) 1993-05-29
JPH0723387B2 (ja) 1995-03-15
GB2201676A (en) 1988-09-07
GR880100084A (el) 1988-12-16
FR2610932A1 (fr) 1988-08-19
IT8847631A0 (it) 1988-02-12
SE467256B (sv) 1992-06-22
DE3804936A1 (de) 1988-09-01
DK168441B1 (da) 1994-03-28
FI880744A (fi) 1988-08-19
ES2011319A6 (es) 1990-01-01
CY1739A (en) 1995-10-20
BE1002427A3 (fr) 1991-02-05
ATA36788A (de) 1990-03-15
ZA881146B (en) 1989-10-25
HUT49361A (en) 1989-09-28
GB2201676B (en) 1991-01-02
HU199858B (en) 1990-03-28
FR2610932B1 (fr) 1990-11-16
AU1175888A (en) 1988-08-25
ES2021904A6 (es) 1991-11-16
LU87129A1 (fr) 1988-09-20
HK142093A (en) 1994-01-07
HU211269A9 (en) 1995-11-28
FI86733C (fi) 1992-10-12
GR1002471B (el) 1996-11-15
AT391320B (de) 1990-09-25
DK79688D0 (da) 1988-02-16
PH25512A (en) 1991-07-24
PT86776A (pt) 1988-03-01
DK79688A (da) 1988-08-19
IL85436A (fr) 1992-12-01
SE8800541A (fr) 1988-08-19
IT1219447B (it) 1990-05-18
KR960015190B1 (ko) 1996-11-01
NL8800412A (nl) 1988-09-16
IE880413L (en) 1988-08-18
FI880744A0 (fi) 1988-02-17
JPS63203691A (ja) 1988-08-23

Similar Documents

Publication Publication Date Title
GB2207672B (en) Sulphonamidothienylcarboxyic acid compounds
JPS6470462A (en) Tetrahydrocarbazole-1-alkanoic acids
US4801609B1 (en) Mercapto-acylamino acid antihypertensives
EP0291245A3 (en) Benzoylaminophenoxybutanoic acid derivatives
EP0308852A3 (en) Solid solution solid solution
GB2203149B (en) New ribofuranuronic acid derivatives
GB8703749D0 (en) Piperazinecarboxylic acid
ZW9288A1 (en) Hydocinnamic acid derivatives
GB2207428B (en) Naphthalenepropionic acid derivatives
GB8723895D0 (en) Preparing-phenyl-propionic acid derivative
AU98521S (en) Sea - or drag - anchor
JPS6413095A (en) 1-aminoethylphosphinic acid
GB2227018B (en) Piperazinylalkylcarboxylic acid adamantylamides
EP0423991A3 (en) 2-trifluoromethyl-4-hydroxybenzoic acid
GB8720908D0 (en) Connection
JPS6413096A (en) 1-aminoethylphosphinic acid derivative
GB8703750D0 (en) Piperazinecarboxylic acid
GB8710781D0 (en) 3-hydroxy-3-methylpentanedioic acid
GB8709020D0 (en) Sulfuric acid
GB8802775D0 (en) Cordgrip
IE871840L (en) 2-penem-3-carboxylic acid compounds
IE872256L (en) Thiopenem-carboxylic acid derivative
IE873378L (en) Furanuronic acid derivatives
IE871285L (en) 2-cyanonicotinic acid derivatives
IE880020L (en) Amino-protected -beta-benzyl- aspartic acid